Lack of interleukin-17 leads to a modulated micro-environment and amelioration of mechanical hypersensitivity after peripheral nerve injury in mice

YJ Day, JT Liou, CM Lee, YC Lin, CC Mao, AH Chou… - PAIN®, 2014 - Elsevier
Abstract Interleukin-17 (IL-17) is involved in a wide range of inflammatory disorders and in
recruitment of inflammatory cells to injury sites. A recent study of IL-17 knock-out mice …

[HTML][HTML] Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice

CF Kim, G Moalem-Taylor - The Journal of Pain, 2011 - Elsevier
Cytokines, essential mediators of inflammatory and immune responses, play an important
role in the pathophysiological processes associated with neuropathic pain following …

Interleukin-17: a putative novel pharmacological target for pathological pain

SJ Gao, L Liu, DY Li, DQ Liu, LQ Zhang… - Current …, 2024 - benthamdirect.com
Pathological pain imposes a huge burden on the economy and the lives of patients. At
present, drugs used for the treatment of pathological pain have only modest efficacy and are …

Interleukin-17A is involved in mechanical hyperalgesia but not in the severity of murine antigen-induced arthritis

M Ebbinghaus, G Natura, G Segond von Banchet… - Scientific reports, 2017 - nature.com
Abstract Interleukin-17A (IL-17A) is considered an important pro-inflammatory cytokine but
its importance in joint diseases such as rheumatoid arthritis (RA) is unclear. It has also been …

Interleukin-17 is involved in neuropathic pain and spinal synapse plasticity on mice

JL Sun, WJ Dai, XY Shen, N Lü, YQ Zhang - Journal of Neuroimmunology, 2023 - Elsevier
Neuropathic pain seriously affects people's life, but its mechanism is not clear. Interleukin-17
(IL-17) is a proinflammation cytokine and involved in pain regulation. Our previous study …

Interleukin-17 as a potential therapeutic target for chronic pain

X Jiang, R Zhou, Y Zhang, T Zhu, Q Li… - Frontiers in …, 2022 - frontiersin.org
Chronic pain remains to be a clinical challenge and is recognized as a major health problem
with varying impacts on quality of life. Currently, the first-line therapy for chronic pain is …

T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression

C Kleinschnitz, HH Hofstetter, SG Meuth… - Experimental …, 2006 - Elsevier
Interleukin (IL)-17A, a recently described novel T cell cytokine, orchestrates inflammation in
a variety of immune-mediated diseases. In the present investigation, we analyzed the …

Interleukin-17 levels in rat models of nerve damage and neuropathic pain

N Noma, J Khan, IF Chen, S Markman, R Benoliel… - Neuroscience …, 2011 - Elsevier
In the present study, we assessed IL-17 levels at 3 and 8 days following various forms of
injuries to the sciatic nerve and related the cytokine levels to the pain behaviors associated …

[HTML][HTML] Interleukin-35 alleviates neuropathic pain and induces an anti-inflammatory shift in spinal microglia in nerve-injured male mice

NT Fiore, JP Hayes, SI Williams… - Brain, behavior, and …, 2024 - Elsevier
Immune cells are critical in promoting neuroinflammation and neuropathic pain and in
facilitating pain resolution, depending on their inflammatory and immunoregulatory cytokine …

Interleukin-17A Acts to Maintain Neuropathic Pain Through Activation of CaMK II/CREB Signaling in Spinal Neurons

C Yao, Z Weng, J Zhang, T Feng, Y Lin, S Yao - Molecular neurobiology, 2016 - Springer
Immunity and neuroinflammation play major roles in neuropathic pain. Spinal interleukin (IL)-
17A, as a mediator connecting innate and adaptive immunity, has been shown to be an …